Prescription of cardioprotective drugs after acute kidney injury

It is estimated that 5% of critically ill patients with acute kidney injury (AKI) require renal replacement therapy (RRT). Increasing data suggests that they have an increased risk of progressive chronic kidney disease, cardiovascular morbidity and premature death. The exact reasons for these poor outcomes following AKI are incompletely understood. Discontinuation of cardioprotective drugs may be an important factor.